BrainStorm Cell Therapeutics
BCLI
#9833
Rank
ยฃ0.93 M
Marketcap
ยฃ0.18
Share price
3.51%
Change (1 day)
7.02%
Change (1 year)

BrainStorm Cell Therapeutics (BCLI) - P/B ratio

P/B ratio as of October 2024 : -0.3471

According to BrainStorm Cell Therapeutics's latest financial reports the company has a price-to-book ratio of -0.3471.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

BrainStorm Cell Therapeutics - P/B ratio (from 2008 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31N/A-100%
2023-12-31-5.18-73.94%
2022-12-31-19.9-364.94%
2021-12-317.5067.23%
2020-12-314.49-155.29%
2019-12-31-8.11-155.24%
2018-12-3114.716.95%
2017-12-3112.6162.05%
2016-12-314.7927.02%
2015-12-313.77-65.37%
2014-12-3110.9-5.92%
2013-12-3111.637.82%
2012-12-318.41-51.47%
2011-12-3117.3-143.66%
2010-12-31-39.7248.5%
2009-12-31-11.4612.96%
2008-12-31-1.60
2007-12-31N/A
2006-12-31N/A
2005-12-31N/A
2004-12-31N/A
2003-12-31N/A
2002-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio differencediff. Country
5.71-1,745.73%๐Ÿ‡บ๐Ÿ‡ธ USA
56.7-16,432.71%๐Ÿ‡บ๐Ÿ‡ธ USA
16.9-4,975.02%๐Ÿ‡บ๐Ÿ‡ธ USA
1.75-604.92%๐Ÿ‡บ๐Ÿ‡ธ USA
-0.5011 44.37%๐Ÿ‡บ๐Ÿ‡ธ USA